761 Pharmacokinetic and pharmacodynamic data from a phase 1 study of CI-8993 Anti-VISTA antibody in patients with advanced solid tumors

Randolph Noelle; Melissa Johnson; Jordi Rodon; Marjorie Zauderer; Lionel Lewis; Mariano Severgnini; Jefferson Parker; Maureen Lane; Reinhard von Roemeling; Alex Martin; Michael Molloy; Robert Martell; Tong Dai

doi:10.1136/jitc-2022-SITC2022.0761

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

761 Pharmacokinetic and pharmacodynamic data from a phase 1 study of CI-8993 Anti-VISTA antibody in patients with advanced solid tumors

Free

Authors

Randolph Noelle Geisel School of Medicine at Dartmouth, Hanover, NH, USA PubMed articles Google scholar articles
Melissa Johnson Tennessee Oncology, Nashville, TN, USA PubMed articles Google scholar articles
Jordi Rodon MD Anderson Cancer Center, Houston, TX, USA PubMed articles Google scholar articles
Marjorie Zauderer Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articles Google scholar articles
Lionel Lewis Geisel School of Medicine at Dartmouth, Hanover, NH, USA PubMed articles Google scholar articles
Mariano Severgnini Curis Inc, Lexington, MA, USA PubMed articles Google scholar articles
Jefferson Parker Curis Inc, Lexington, MA, USA PubMed articles Google scholar articles
Maureen Lane Curis Inc, Lexington, MA, USA PubMed articles Google scholar articles
Reinhard von Roemeling Curis Inc, Lexington, MA, USA PubMed articles Google scholar articles
Alex Martin Curis Inc/Tufts Medical Center, Lexington, MA, USA PubMed articles Google scholar articles
Michael Molloy ImmuNext Inc, Lebanon, NH, USA PubMed articles Google scholar articles
Robert Martell Curis Inc, Lexington, MA, USA PubMed articles Google scholar articles
Tong Dai Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA PubMed articles Google scholar articles

Citation

Noelle R, Johnson M, Rodon J, et al

761 Pharmacokinetic and pharmacodynamic data from a phase 1 study of CI-8993 Anti-VISTA antibody in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0761

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password